Concord Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Concord Medical Services Holdings Limited (CCM)

Q1 2012 Earnings Call

May 22, 2012 08:00 am ET

Executives

Tony Tian – Investor Relations Manager

Jianyu Yang – Chairman of the Board and Chief Executive Officer

Adam J. Sun – Chief Financial Officer

Zheng Cheng – President and Chief Operating Officer; Director

Analysts

Christopher Lui – Morgan Stanley Asia Ltd.

Yale I. Jen – ROTH Capital Partners LLC

Sean Wu – JPMorgan Securities (Asia Pacific) Ltd.

Presentation



Operator

» Medtronic Management Discusses Q4 2012 Results - Earnings Call Transcript
» Brookdale Senior Living's CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
» Schiff Nutrition International's CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)

Hello and thank you for standing by for Concord Medical’s first quarter 2012 earnings conference call. At this time, all participants are in listen-only mode. After management’s prepared remarks, there will be a question-and-answer session. Today’s conference is being recorded. If you have any objections you may disconnect at this time.

I would now like to turn the meeting over to your host for today’s conference, Tony Tian, Investor Relations Manager of Concord Medical.

Tony Tian

Hello everyone and welcome to Concord Medical’s first quarter 2012 earnings conference call. Concord Medical’s earnings release was distributed earlier today and you can find a copy on our website as well as on newswire services.

Today, you will hear from Dr. Jianyu Yang, Concord Medical’s Chairman and Chief Executive Officer, and Mr. Adam Sun, Chief Financial Officer. After their prepared remarks, Dr. Yang and Mr. Sun will be available to answer your questions.

Before we continue, please note that the discussion today will contain forward-looking statements made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from our current expectations. Potential risks and uncertainties include but are not limited to those outlined in our public filings with the SEC. Concord Medical does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

1 2 3 Next › Last »